Apr 26, 2021
In the first segment, Dr. Jeff Burns speaks with Prof. Maria Eriksdotter about whether Cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk. In the second part of the podcast, Dr. David Lapides talks with Dr. Martijn Wijburg about pharmacovigilance of patients treated...
Apr 22, 2021
Dr. Derek Stitt speaks with FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks about cases of thrombosis after the Johnson & Johnson COVID-19 vaccine, potential risk factors, and suggestions for patient care.
Apr 19, 2021
In the first segment, Dr. Ted Burns talks with Drs. P. James B. Dyck and Shahar Shelly about clinical, neurophysiological, and pathological features of CISP-plus in comparison to CISP. In the second part of the podcast, Dr. David Lapides discusses important ethical issues encountered in neurological clinical research...
Apr 12, 2021
In the first segment, Dr. David Lapides talks with Dr. Nicolas Collongues about pregnancy in patients with neuromyelitis optica spectrum disorder. In the second part of the podcast, Dr. Jason Crowell discusses racial and ethnic health disparities exacerbated by COVID-19 with Drs. Leo Lopez III and Louis Hart.
Apr 5, 2021
In the first segment, Dr. Stacey Clardy talks to Jade Smith about financial conflicts of interest of authors published in high-impact neurology journals. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Emily Largent about potential advancements and ethical challenges associated with blood...